Pharma Mar | PHM - Interest Expense On Debt

Stock Price
77.60
Daily Change
1.00 1.31%
Monthly
3.60%
Yearly
-15.28%
Q1 Forecast
76.83

Pharma Mar reported EUR117K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
IQVIA Holdings USD 189M 7M Sep/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Revvity USD 22.77M 166K Sep/2025
Tectonic Therapeutic USD 277M 276.98M Sep/2025
Viatris USD 119.6M 3M Sep/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025